24 June 2019 - Deborah Wilkes
Orkla, GNC, Orbis Biosciences and McKesson have also recently announced people changes.
Orkla recruits new chief executive
Orkla has recruited Jaan Ivar Semlitsch as its new president and chief executive officer with effect from 15 August 2019.
Semlitsch joins the Norwegian consumer goods company from Dixons Carphone where he has been chief executive officer of Elkjop Nordic for more than six years. For the past year, he has also been chief executive officer of Dixons Carphone's international operations.
Before joining Dixons Carphone, Semlitsch was chief executive officer of Rema Industrier and chief executive officer of Plantasjen. He has also worked for Statoil Retail Europe, Expert Denmark and McKinsey & Company.
Semlitsch will take over from Terje Andersen who has been acting president and chief executive officer of Orkla since the departure of Peter Ruzicka on 7 May 2019.
GNC reshapes management
GNC has hired Ryan Ostrom as chief brand officer in a leadership restructuring designed to capitalise on "key growth areas in brand, digital, e-commerce and international".
Ostrom joins the US-based health, wellness and performance retailer from KFC where he was global chief digital officer with responsibility for developing and executing the company's global digital strategy.
At GNC, Ostrom will lead the brand, marketing, digital and e-commerce strategy. He will report directly to Ken Martindale, GNC's chairman and chief executive officer.
As part of the leadership restructuring, GNC has also promoted Carl Seletz to chief global officer with immediate effect. Seletz, who has been GNC's senior vice president of international for the past six years, will continue to report to Martindale.
In addition, Rachel Jones has been promoted to vice president of global brands with responsibility for product brand strategy development and execution across all GNC-owned product lines. She will report to Ostrom.
Jones was previously vice president of international merchandising and marketing at GNC. She has been with the company for over 15 years.
Commenting on the changes, Martindale said: "Ryan, Carl and Rachel will all play critical roles in executing our strategy to create seamless customer experiences across channels, grow our global presence and further leverage the power of our brand and broad product portfolio."
Orbis boosts business development team
Drug delivery specialist Orbis Biosciences has appointed Karl Strohmeier as chief licensing officer and Brad Spitz as vice president of business development. Strohmeier joins from Teva Pharmaceuticals, while Spitz joins from ANGLE North America.
McKesson expands board
McKesson has announced that Ken Washington is joining its Board of Directors as a new independent director, taking the total number of members up to 10.
Washington has been chief technology officer of Ford Motor Company since June 2017. Before joining Ford, he was vice president of the Advanced Technology Center at Lockheed Martin Space Systems Company.
The US-based drug distributor said Washington's "years of experience in technology, research and privacy strategy at complex global organisations will be invaluable".
Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE